Abbott Laboratories vs UnitedHealth Group Incorporated — Stock Comparison
Abbott Laboratories (ABT) and UnitedHealth Group Incorporated (UNH) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Abbott Laboratories scores ahead of UnitedHealth Group Incorporated on Q·Score (7.1 vs 6.1 out of 10), led by Valuation (8.6 vs 6.5) and Quality (7.7 vs 5.9). UnitedHealth Group Incorporated scores higher on Sentiment, reflecting stronger analyst and market sentiment. Analyst consensus targets imply greater upside for ABT (+31.4%) than for UNH (-0.9%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Consensus analyst target of $116.54 is 31% above current price.
⚠ earnings contracting 20% year-over-year.
82% of 28 covering analysts have a positive rating.
⚠ limited growth momentum.
Analyst Consensus
Fundamentals
Frequently Asked Questions
ABT vs UNH: which stock scores better overall?
Based on Q·Score, Abbott Laboratories (ABT) scores 7.1/10 versus UnitedHealth Group Incorporated (UNH) at 6.1/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: ABT or UNH?
UnitedHealth Group Incorporated (UNH) scores higher on Growth (5.1/10 vs 4.7/10). Abbott Laboratories reports revenue growth (7.8% YoY) while UnitedHealth Group Incorporated reports (2.0% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is ABT or UNH more attractively valued?
Abbott Laboratories (ABT) scores higher on Valuation (8.6/10 vs 6.5/10). ABT trades at 14.6× P/E versus UNH at 19.7×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about ABT vs UNH?
There are 24 analysts covering ABT with a consensus price target of $116.54, and 26 analysts covering UNH with a consensus target of $407.38. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: ABT or UNH?
Abbott Laboratories (ABT) scores higher on Quality (7.7/10 vs 5.9/10). Net profit margin: ABT at 13.9%, UNH at 2.7%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: ABT or UNH?
Abbott Laboratories (ABT) scores higher on Financial Health (7/10 vs 5.3/10). Market beta: ABT at 0.62, UNH at 0.65. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of ABT and UNH?
Abbott Laboratories (ABT) has a market capitalisation of $154.4B, while UnitedHealth Group Incorporated (UNH) has a market cap of $373.3B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do ABT or UNH pay dividends?
ABT pays a dividend yield of 2.84%, while UNH pays a dividend yield of 2.26%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →